SCM
MEDP icon

Shelton Capital Management’s Medpace MEDP Stock Holding History

Shelton Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Sell
725
-26
-3% -$12K 0.01% 452
2026
Q1 		$361K Hold
751
– – 0.01% 454
2025
Q4 		$422K Sell
751
-84
-10% -$47.7K 0.01% 393
2025
Q3 		$429K Sell
835
-60
-7% -$26.2K 0.01% 398
2025
Q2 		$281K Sell
895
-25
-3% -$7.51K 0.01% 511
2025
Q1 		$280K Hold
920
– – 0.01% 501
2024
Q4 		$306K Hold
920
– – 0.01% 498
2024
Q3 		$307K Hold
920
– – 0.01% 490
2024
Q2 		$379K Sell
920
-97
-10% -$38.4K 0.01% 402
2024
Q1 		$411K Hold
1,017
– – 0.01% 407
2023
Q4 		$312K Sell
1,017
-131
-11% -$35.4K 0.01% 481
2023
Q3 		$278K Sell
1,148
-93
-7% -$23.8K 0.01% 505
2023
Q2 		$298K Sell
1,241
-57
-4% -$11.8K 0.01% 499
2023
Q1 		$244K Buy
1,298
+13
+1% +$2.69K 0.01% 583
2022
Q4 		$273K Sell
1,285
-130
-9% -$26K 0.03% 484
2022
Q3 		$222K Sell
1,415
-114
-7% -$18.2K 0.01% 587
2022
Q2 		$229K Hold
1,529
– – 0.01% 613
2022
Q1 		$250K Hold
1,529
– – 0.01% 661
2021
Q4 		$333K Hold
1,529
– – 0.01% 513
2021
Q3 		$289K Hold
1,529
– – 0.01% 574
2021
Q2 		$270K Hold
1,529
– – 0.01% 634
2021
Q1 		$251K Buy
+1,529
New +$234K 0.01% 635
2020
Q4 		– Sell
-1,878
Closed -$210K – 785
2020
Q3 		$210K Buy
+1,878
New +$217K 0.01% 670
2020
Q1 		– Sell
-2,426
Closed -$204K – 756
2019
Q4 		$204K Sell
2,426
-169
-7% -$13.1K 0.01% 759
2019
Q3 		$218K Buy
+2,595
New +$196K 0.01% 714

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Shelton Capital Management's MEDP Position: Q2 2026 in Review

Shelton Capital Management reduced its Medpace (MEDP) stake by 3.5% in Q2 2026, selling an estimated $12K and leaving 725 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #452.

Shelton Capital Management first reported a position in MEDP in Q3 2019 and has held it in 25 quarters since. The position peaked at $429K in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Shelton Capital Management held 725 shares of Medpace worth $384K as of Q2 2026.
  • Shelton Capital Management sold 26 Medpace shares in Q2 2026, an estimated $12K.
  • Medpace made up 0.01% of Shelton Capital Management's portfolio in Q2 2026, its #452 holding.
  • Shelton Capital Management first reported a position in Medpace in Q3 2019 and has held it in 25 quarters since.
  • Shelton Capital Management's Medpace position peaked at $429K in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.